The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Microalbumin Random Urine with Creatinine
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
Also known as: Insulin (fasting)
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
The Diabetes Management - Advanced panel contains 7 tests with 68 biomarkers.
Brief Description: The Diabetes Management - Advanced panel is an extensive diagnostic tool designed to provide a thorough evaluation of a patient’s diabetic status and associated health risks. This panel includes a comprehensive range of tests that assess blood glucose control, kidney function, lipid metabolism, insulin levels, and overall metabolic health. The combination of these tests offers a holistic view of a diabetic patient's condition, enabling healthcare providers to develop effective management and treatment plans.
Collection Method: Blood Draw and Urine Collection
Specimen Type: Whole Blood, Serum, and Urine
Test Preparation: Patient should be fasting 9-12 hours prior to collection
The Diabetes Management - Advanced panel may be ordered for individuals who have been diagnosed with diabetes and require detailed monitoring to manage their condition effectively. It is particularly useful for patients experiencing complications or those who have not achieved optimal glucose control with their current treatment regimen. Additionally, this panel is recommended for individuals at high risk of developing diabetes, such as those with a family history of diabetes, obesity, or other metabolic risk factors.
The Diabetes Management - Advanced panel includes several critical tests that provide insights into various aspects of a patient's health:
Complete Blood Count with Differential and Platelets
This test evaluates overall blood health, including the number and types of blood cells. It helps detect conditions such as anemia, infection, and other hematological disorders that can complicate diabetes management.
The CMP assesses kidney and liver function, electrolyte balance, and glucose levels. This test is crucial for identifying potential complications of diabetes, such as kidney damage and liver dysfunction.
Cystatin C is a marker for kidney function that provides a more sensitive assessment of glomerular filtration rate (GFR) than creatinine. Elevated levels can indicate early kidney disease, a common complication of diabetes.
Hemoglobin A1c (HbA1c) measures the average blood glucose concentration over the past two to three months. It is a key indicator of long-term glucose control and helps evaluate the effectiveness of a diabetes treatment plan.
The insulin test measures the level of insulin in the blood. It helps assess insulin production and resistance, providing insights into the patient’s metabolic health and guiding treatment adjustments.
This test measures total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides, providing ratios that assess cardiovascular risk. It is essential for managing diabetes-related cardiovascular complications.
Microalbumin, Random Urine with Creatinine
This test measures the amount of albumin in the urine, which can indicate early kidney damage. The inclusion of creatinine helps account for variations in urine concentration, providing a more accurate assessment of kidney health.
For those seeking an even more detailed evaluation of their diabetic health, the Diabetes Management - Comprehensive panel offers additional insights beyond the Advanced panel.
The Diabetes Management - Comprehensive panel includes all tests from the Advanced panel, plus Apolipoprotein A1, Apolipoprotein B, and C-Reactive Protein. Apolipoprotein A1 and B provide detailed information about lipid particles, enhancing cardiovascular risk assessment. C-Reactive Protein measures inflammation, a critical factor in diabetes management and cardiovascular health.
The Diabetes Management - Advanced panel is essential for detecting and monitoring various conditions associated with diabetes:
Diabetes Mellitus
This panel provides a comprehensive assessment of blood glucose control through Hemoglobin A1c and insulin levels, reflecting both long-term and immediate glucose management.
Diabetic Nephropathy
Microalbumin and Cystatin C tests are crucial for detecting early signs of kidney damage, a common complication of diabetes. Early detection allows for timely intervention to prevent progression.
Cardiovascular Disease
The Lipid Panel with Ratios helps assess the risk of cardiovascular disease by measuring cholesterol levels and ratios. Diabetic patients are at a higher risk for heart disease, making this test critical for managing their health.
Diabetes Mellitus
Healthcare professionals use Hemoglobin A1c and insulin results to evaluate how well a patient's blood glucose levels are controlled. This information guides adjustments in medication, diet, and lifestyle to improve glucose management.
Diabetic Nephropathy
Detecting microalbumin in the urine and elevated Cystatin C levels indicate early kidney damage. Physicians use these results to implement strategies to protect kidney function, such as tighter control of blood pressure and blood sugar levels, and possibly prescribing medications to reduce kidney strain.
Cardiovascular Disease
Lipid panel results guide interventions to manage cholesterol levels and reduce cardiovascular risk. This may include lifestyle changes, dietary adjustments, and medications such as statins to lower LDL cholesterol and triglycerides while increasing HDL cholesterol.
The Diabetes Management - Advanced panel provides a comprehensive evaluation of essential health markers for individuals with diabetes. By assessing blood health, metabolic function, glucose control, kidney health, and cardiovascular risk, this panel offers valuable insights that help healthcare providers optimize treatment plans, detect complications early, and improve overall patient outcomes. Regular monitoring through this advanced panel supports proactive diabetes management and helps patients maintain better control over their health.